Pfizer Can't Escape Neurontin Antitrust MDL

Law360, New York (August 8, 2013, 3:37 PM EDT) -- A New Jersey federal judge on Thursday refused Pfizer Inc.'s bid to squash a multidistrict litigation accusing the pharmaceutical giant of conspiring to bar competition for its epilepsy treatment Neurontin and promoting off-label uses, saying there are many factual disputes that must be resolved. 

Pfizer had sought summary judgment on all claims in the suit while a group of direct purchaser plaintiffs wanted a summary judgment ruling on their allegations that Pfizer possessed monopoly power. But U.S. District Judge Faith S. Hochberg struck both sides' requests...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.